Bibliography
Found 365 results
Filters: Keyword is Internal [Clear All Filters]
Cerebral volumetric and metabolic abnormalities in HIV associated neurocognitive disorders (HAND). 2017 .
Human immunodeficiency virus and the central nervous system. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases [Internet]. 2006 ;10:41-50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16767315
. Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS. 2009 ;23(17):2317-22.
. Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology [Internet]. 2007 ;27:86-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17226745
. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. J Neurovirol. 2015 ;21(5):559-67.
Brain morphometric correlates of metabolic variables in HIV: the CHARTER study. J Neurovirol. 2014 ;20(6):603-11.
Socioeconomic Status and Neuropsychological Functioning: Associations in an Ethnically Diverse HIV+ Cohort. Clin Neuropsychol. 2015 ;29(2):232-54.
. Socioeconomic status and neuropsychological functioning: Associations in an ethnically diverse HIV+ cohort. Clinical Neuropsychology. 2015 ;29(2):232-254.
. The utility of norms based on education versus reading ability in the prediction of functional impairment in HIV-infection. In: Journal of the International Neuropsychology Society. Vol. 10. Journal of the International Neuropsychology Society. ; 2004. p. 196.
. Neuropsychological effects of HIV and Hepatitis C co-infection. In: 34th Annual Meeting of the International Neuropsychological Society. 34th Annual Meeting of the International Neuropsychological Society. Boston, MA; 2006.
. . Neurocognitive outcomes in HIV+ abstinent cocaine versus methamphetamine users. In: 2nd Annual AIDS Research Symposium at UCLA. 2nd Annual AIDS Research Symposium at UCLA. ; 2009.
. Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr. 2012 ;59(4):376-81.
Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 ;23(1):83-7.
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother. 2011 ;66(2):354-7.
Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol. 2011 ;52(4):328-32.
Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort. J HIV AIDS Soc Serv. 2014 ;13(1):8-25.
. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012 ;18(1):79-88.
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012 ;26(6):894-908.
Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 ;29(3):323-30.
. Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection. J Neuroimmune Pharmacol. 2016 ;11(2):279-93.
. Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr. 2011 ;58(2):154-62.
Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study. Journal of the International Neuropsychological Society (JINS) [Internet]. 2013 ;19(4):463-473. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23446056
. HIV-Related Cognitive Disorders in U.S. Ethnic Minorities: Influence of confounds and classification systems. In: 34th Annual Meeting of the International Neuropsychological Society. 34th Annual Meeting of the International Neuropsychological Society. ; 2006.
. Prospective memory in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology [Internet]. 2006 ;28:536-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16676475
.